Y-Intercept (HK)’s Agios Pharmaceuticals AGIO Stock Holding History

Y-Intercept (HK)’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.84M	Buy	+85,516	New	+$2.99M	0.06%	454
2026 Q2	–	Sell	-13,866	Closed	-$469K	–	1662
2026 Q1	$469K	Sell	13,866 -65,965	-83%	-$1.87M	0.01%	1272
2025 Q4	$2.17M	Buy	79,831 +71,899	+906%	+$2.52M	0.05%	590
2025 Q3	$318K	Buy	+7,932	New	+$298K	0.01%	1362
2025 Q1	–	Sell	-45,817	Closed	-$1.51M	–	1154
2024 Q4	$1.51M	Buy	+45,817	New	+$2.15M	0.1%	283
2024 Q3	–	Sell	-25,945	Closed	-$1.12M	–	1257
2024 Q2	$1.12M	Buy	+25,945	New	+$936K	0.06%	446
2022 Q4	–	Sell	-11,246	Closed	-$318K	–	962
2022 Q3	$318K	Buy	+11,246	New	+$302K	0.03%	686

Other funds holding AGIO

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Y-Intercept (HK)'s AGIO Position: Q3 2026 in Review

Y-Intercept (HK) opened a new position in Agios Pharmaceuticals (AGIO) in Q3 2026: 85,516 shares worth $2.84M. The stake represents 0.06% of the portfolio and ranks #454 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in AGIO as recently as Q1 2026.

Y-Intercept (HK) first reported a position in AGIO in Q3 2022 and has held it in 7 quarters since. 20 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.

Y-Intercept (HK) held 85,516 shares of Agios Pharmaceuticals worth $2.84M as of Q3 2026.
Agios Pharmaceuticals was a new Y-Intercept (HK) position in Q3 2026.
Agios Pharmaceuticals made up 0.06% of Y-Intercept (HK)'s portfolio in Q3 2026, its #454 holding.
Y-Intercept (HK) first reported a position in Agios Pharmaceuticals in Q3 2022 and has held it in 7 quarters since.
20 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.